Table 2.
Demographics and Baseline Investigations of CD Patients with PHT (n = 29).
| Parameter | Group A (n = 17). Median (Range) |
Group B (n = 12) Median (Range) |
|---|---|---|
| ETIOLOGY | cCLD [n = 13] | NCPF [n = 11] |
| HBV (n = 2) | EHPVO (n = 1) | |
| AIH (n = 1) | ||
| BCS (n = 1) | ||
| AGE (years) | 33.5 (27–65) | 24.5 (15–42) |
| SEX | M (n = 424) F (n = 13 [76%]) |
M (n = 2 [17%]) F (n = 10 [83%]) |
| Hb (g/dl) | 8.1 (5.1–11.2) | 6.9 (3.8–9.2) |
| TLC (cumm) | 6650 (3400–9020) | 4590 (1400–6810) |
| Platelets (lacs/ml) | 0.76 (0.35–1.59) | 0.68 (0.33–1.32) |
| INR | 1.87 (1.4–3.9) | 1.2 (1.09–1.3) |
| Bilirubin (mg/dl) | 2.9 (1.9–10) | 1.1 (0.9–1.4) |
| SGOT (U/L) | 97 (26–212) | 39.5 (19–44) |
| SGPT (U/L) | 61 (39–102) | 35 (25–38) |
| ALP (U/L) | 166 (45–233) | 112 (36–145) |
| TOTAL PROTEIN (g/dl) | 5.2 (4.5–7.6) | 6.6 (5.9–7.1) |
| GLOBULIN (g/dl) | 3.1 (2.2–4.3) | 2.9 (2.6–3.1) |
| ALBUMIN (g/dl) | 2.4 (1.7–3.8) | 3.7 (3.6–4.1) |
| CREATININE (mg/dl) | 1.4 (0.6–2.3) | 0.8 (0.7–1.1) |
| Ig-A anti-tTG titre- | 2 folds (n = 2) | 2 folds (n = 0) |
| 3–5 folds (n = 1) | 3–5 folds (n = 3) | |
| 6–10 folds (n = 4) | 6–10 folds (n = 5) | |
| >10 folds (n = 10) | >10 folds (n = 4) |